Derren Nathan, head of equity research, Hargreaves Lansdown: “Markets have entered Friday in a positive mood. The FTSE is up taking its cue from Wall Street and eastern exchanges as…
GSK
Market Report – Retail sales disappoint in a big way, US business activity muddies interest rate outlook
Sophie Lund-Yates, lead equity analyst, Hargreaves Lansdown: “Retail sales have sunk by far more than expected in the UK. There was a highly disappointing 2.3% decline in April, from a…
GSK – Strong first quarter prompts another upgrade Derren Nathan, head of equity research, Hargreaves Lansdown: “GSK has started 2024 in rude health. Strong growth in vaccine and speciality medicines…
Steve Clayton, head of equity funds, Hargreaves Lansdown: “While the UK grappled with its first nationwide Covid-19 lockdown four years ago, Pfizer was winning the race to develop the first…
NatWest boss Rose steps down, and stocks dip ahead of Fed decision – plus LVMH, Rolls Royce, Rio Tinto, Lloyds and GSK
Steve Clayton, head of equity funds, Hargreaves Lansdown: “A nervous trading session in Asia saw some of yesterday’s euphoria wiped away, ahead of tonight’s rate decision by the US Federal…